This episode, Driving Quality Initiatives Now and Into The Future, is the second of a two-part conversation.  In part one of this conversation, Julie Barnes from Maverick Health Policy discussed the evolving CMS quality measure guidance due to COVID-19.

In this episode, Rebecca Molesworth, Medecision’s Senior Director of Data Intelligence, continues the conversation around quality measurement with our guest, Kevin Weinstein, who is the President of the Population Health Division of SPH Analytics. 

They discuss the heightened importance of a value-based approach, what quality initiatives may look like in a post-COVID-19 world, and how the Medecision and SPH partnership is transforming quality measurement.

In this episode, Dr. Carolyn Smith discusses the principles of bioethics during the COVID-19 pandemic, the public health code of ethics, and triage and the allocation of scare resources. She examines the ethics of research, end of life issues, and moral distress facing everyone involved in this pandemic. 

In this episode, Medecision Advisory Board Chair, Dr. Richard Popiel, examines some of the early trends that may define our new normal, and highlight how the healthcare industry - and society at large - are likely to look fundamentally different in a post-COVID world.

In this episode, A Discussion About Novel Coronavirus – Facts, Lessons and a New Revolution, our Executive Vice President and Chief Marketing and Customer Experience Officer Ellen Dalton facilitates a conversation with Medecision Advisory Board member, Doctor Terry McInnis.

Doctor Jan Berger gives us some thought-provoking perspectives around what Population Health looks like during, as well as after the COVID-19 pandemic, and what that may mean for the healthcare ecosystem.

Terri Kline, an epidemiologist, Medecision Advisory Board member, and long-time partner gives us some fascinating and valuable perspectives around what’s happening with the COVID-19 pandemic and the implications it may have on our healthcare ecosystem.